Medtronic (NYSE:MDT) the medical device maker is proposing a $800 million deal to acquire Ardian. Ardian is a medical device maker with the latest high blood pressure catheter therapy. The deal is all cash payout. The Vice President of Medtronic, Sean Salmon stated that the deal also involves using Ardian’s technology to increase the annual revenue till the end of 2015.
Medtronic (NYSE:MDT) currently owns more than 11% stake in Ardian. The newest catheter blood pressure therapy received appreciation at the recent American Heart Association scientific meeting. It has managed to reduce blood pressure on an average by up to 33 points in high BP patients after 6 months.
Related posts:
- Bird Flu Resurfaces
- Pfizer’s Help With Heart Disease
- Lowering Cholesterol Getting Easier
- Japanese Firm buying Genzyme
- Jane Fonda Confirms breast Cancer
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.